Silverfin false false 29/02/2024 29/02/2024 01/03/2023 The principal activity of the Company during the financial year was specialist medical practice activities. Lucy Josephine Dale 18/02/2020 Dr Oliver Thomas Dale 18/02/2020 12470054 2024-02-29 12470054 bus:Director1 2024-02-29 12470054 bus:Director2 2024-02-29 12470054 2023-02-28 12470054 core:CurrentFinancialInstruments 2024-02-29 12470054 core:CurrentFinancialInstruments 2023-02-28 12470054 2023-03-01 2024-02-29 12470054 bus:Micro-entities 2023-03-01 2024-02-29 12470054 bus:FilletedAccounts 2023-03-01 2024-02-29 12470054 bus:AuditExemptWithAccountantsReport 2023-03-01 2024-02-29 12470054 bus:PrivateLimitedCompanyLtd 2023-03-01 2024-02-29 12470054 bus:Director1 2023-03-01 2024-02-29 12470054 bus:Director2 2023-03-01 2024-02-29 12470054 2022-03-01 2023-02-28 iso4217:GBP xbrli:pure

Company No: 12470054 (England and Wales)

BRISTOL ENT SURGERY LIMITED

Unaudited Financial Statements
For the financial year ended 29 February 2024
Pages for filing with the registrar

BRISTOL ENT SURGERY LIMITED

UNAUDITED FINANCIAL STATEMENTS

For the financial year ended 29 February 2024

Contents

BRISTOL ENT SURGERY LIMITED

BALANCE SHEET

As at 29 February 2024
BRISTOL ENT SURGERY LIMITED

BALANCE SHEET (continued)

For the financial year ended 29 February 2024
2024 2023
£ £
Fixed assets 50,358 1,628
Current assets 204,588 226,864
Creditors: amounts falling due within one year ( 17,658) ( 37,495)
Net current assets 186,930 189,369
Total assets less current liabilities 237,288 190,997
Accruals and deferred income ( 1,411) ( 1,333)
Net assets 235,877 189,664
Capital and reserves 235,877 189,664

For the financial year ending 29 February 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Bristol ENT Surgery Limited (registered number: 12470054) were approved and authorised for issue by the Board of Directors on 26 November 2024 and were signed on its behalf by:

Dr Oliver Thomas Dale
Director
BRISTOL ENT SURGERY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 29 February 2024
BRISTOL ENT SURGERY LIMITED

NOTES TO THE FINANCIAL STATEMENTS (continued)

For the For the financial year ended 29 February 2024

1. Company information

The Company is a private company limited by shares and is incorporated in the United Kingdom and registered in England and Wales (Company no. 12470054). The address of its registered office is 5th Floor, 25 King Street, Bristol, BS1 4PB, United Kingdom.

2. Employees

2024 2023
Number Number
Monthly average number of persons employed by the Company during the financial year, including directors 2 2

3. Directors’ benefits: advances, credit and guarantees

Advances

The Directors loan account is repayable on demand and interest is charged on overdrawn balances exceeding £10,000 at the official HMRC rates.

At 1 March 2023, the balance owed by the directors was £41,503. During the year, £14,154 was advanced to the directors, and £42,220 was repaid by the directors. At 28 February 2024, the balance owed by the directors was £13,437.

At 1 March 2022, the balance owed by the directors was £14,910. During the year, £27,710 was advanced to the directors, and £1,117 was repaid by the directors. At 28 February 2023, the balance owed by the directors was £41,503.